Pay in 4 interest-free payments of $6.61 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Prescription Access New Patients vs Renewal-Only Policies This is the most structurally important difference between the two programs and the factor that most definitively determines which platform a new patient should choose
doi:10.1016/j.diabres.2021.108899 Fathy MA, Anbaig A, Aljafil R, et al
Liisa AM Galea - Funding acquisition, Project administration, Resources, Supervision, Validation, Writing review & editing
Cardiovascular outcome trials in patients with diabetes The Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes (EXSCEL) study looked at the CV effects of once-weekly exenatide in T2D patients (the median baseline HgA1c was 8%)
Regarding safety in real-world practice, these large observational studies have not identified unexpected safety signals beyond those known from clinical trials
US$ 25.67
US$ 26.32
US$ 24.73
